PTC Therapeutics (PTCT)

PTC Therapeutics (PTCT) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• PTCT last traded at $61.36, 2.32% on the day.
• PTC Therapeutics: market cap $5.01B, P/E -46.8, revenue $1.16B over the last four quarters.
• Over the past year PTCT returned -9.91%; year to date -19.22%.

Updated 2026-11-02 19:08 UTC